» Authors » Javier Escaned

Javier Escaned

Explore the profile of Javier Escaned including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 606
Citations 12592
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Berry C, Camici P, Crea F, George M, Kaski J, Ong P, et al.
Int J Cardiol . 2025 Mar; :133162. PMID: 40088955
Patients with angina and non-obstructive coronary arteries (ANOCA) or myocardial ischaemia with non-obstructive coronary arteries (INOCA) comprise a relatively large subgroup within those with ischaemic heart disease. Advances in the...
2.
Onuma Y, Ninomiya K, Sjauw K, Damman P, Matsuo H, von Birgelen C, et al.
Am Heart J . 2025 Mar; PMID: 40081745
Background: Angiography-derived Fractional Flow Reserve (FFR) software has been developed using pressure wire based FFR as the reference, however most software requires two angiographic views ≥25 degrees apart limiting their...
3.
Boerhout C, Namba H, Liu T, Beijk M, Damman P, Meuwissen M, et al.
Am Heart J . 2025 Mar; PMID: 40068714
Angina with non-obstructive coronary arteries (ANOCA) is a major cause of chronic coronary syndromes, affecting nearly half of patients with anginal symptoms who undergo invasive coronary angiography. ANOCA may lead...
4.
Lombardi M, Holck E, Jeronimo A, Salinas P, Gonzalo N, Christiansen E, et al.
J Soc Cardiovasc Angiogr Interv . 2025 Mar; 4(1):102452. PMID: 40061420
Background: Physiological changes in the coronary circulation associated with percutaneous coronary intervention (PCI) for chronic total occlusions (CTOs) remain largely unknown. This systematic review and meta-analysis aimed to investigate physiological...
5.
Zhao Y, Guan C, Wang Y, Jin Z, Yu B, Fu G, et al.
Chin Med J (Engl) . 2025 Mar; PMID: 40025631
Background: The FAVOR (Comparison of Quantitative Flow Ratio Guided and Angiography Guided Percutaneous Intervention in Patients with Coronary Artery Disease) III China trial demonstrated that percutaneous coronary intervention (PCI) lesion...
6.
Shabbir A, Ali Z, Colletti G, Dudek D, Garbo R, Hellig F, et al.
JACC Cardiovasc Interv . 2025 Feb; 18(4):409-424. PMID: 40010912
Since its inception, percutaneous coronary intervention (PCI) has relied upon vessel opacification with iodinated contrast to plan, guide, and assess the results of the procedure. Yet revisiting this fundamental concept...
7.
Revaiah P, Tsai T, Chinhenzva A, Miyashita K, Tobe A, Oshima A, et al.
JACC Cardiovasc Interv . 2025 Feb; PMID: 39985510
Background: Fractional flow reserve (FFR) and instantaneous wave-free ratio (iFR) are discordant in approximately 20% of cases, and it is unclear whether this is influenced by the physiological pattern of...
8.
Choi K, Nam C, Bruno F, Cho Y, De Luca L, Kang J, et al.
J Am Heart Assoc . 2025 Feb; 14(3):e037657. PMID: 39895551
Background: Although true bifurcation lesions are associated with a high risk of procedural complications, the differential prognostic implications of percutaneous coronary intervention for true bifurcations according to lesion location are...
9.
Steg P, Nicolas J, Baber U, Sartori S, Zhang Z, Feng Y, et al.
Am Heart J . 2025 Jan; PMID: 39889917
Background: The TWILIGHT trial showed that, among high-risk patients who underwent percutaneous coronary intervention (PCI) and were event-free at 3 months, ticagrelor monotherapy versus ticagrelor plus aspirin reduced bleeding without...
10.
Paolucci L, Shabbir A, Lombardi M, Jeronimo A, Escaned J, Gonzalo N
Interv Cardiol . 2025 Jan; 19():e26. PMID: 39872904
Stent underexpansion (SU) and aorto-ostial lesions (AOL) are challenging conditions commonly faced during clinical practice in the setting of percutaneous coronary interventions. Compared to other interventional settings, both SU and...